Growth Metrics

Eli Lilly (LLY) Inventory Average (2016 - 2025)

Historic Inventory Average for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $13.0 billion.

  • Eli Lilly's Inventory Average rose 7226.89% to $13.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $13.0 billion, marking a year-over-year increase of 7226.89%. This contributed to the annual value of $10.7 billion for FY2025, which is 5965.66% up from last year.
  • Eli Lilly's Inventory Average amounted to $13.0 billion in Q4 2025, which was up 7226.89% from $11.6 billion recorded in Q3 2025.
  • Eli Lilly's Inventory Average's 5-year high stood at $13.0 billion during Q4 2025, with a 5-year trough of $3.7 billion in Q2 2021.
  • Over the past 5 years, Eli Lilly's median Inventory Average value was $4.8 billion (recorded in 2023), while the average stood at $6.0 billion.
  • As far as peak fluctuations go, Eli Lilly's Inventory Average decreased by 2.33% in 2022, and later skyrocketed by 7226.89% in 2025.
  • Eli Lilly's Inventory Average (Quarter) stood at $3.9 billion in 2021, then rose by 4.46% to $4.1 billion in 2022, then soared by 31.12% to $5.3 billion in 2023, then surged by 40.98% to $7.5 billion in 2024, then surged by 72.27% to $13.0 billion in 2025.
  • Its Inventory Average stands at $13.0 billion for Q4 2025, versus $11.6 billion for Q3 2025 and $10.2 billion for Q2 2025.